ESR1 and breast neoplasm: We have observed that the neoplastic cells that express nuclear hPXR1.2 and no ER immunoreactivity were strongly correlated; this inverse correlation between both receptors suggests that pathways by hPXR-mediated might be functional in breast tumours with potential poor response to the endocrine adjuvance.